Research ArticleArticle
Pharmacokinetics, Biotransformation, and Mass Balance of Edoxaban, a Selective, Direct Factor Xa Inhibitor, in Humans
Mohinder S. Bathala, Hiroshi Masumoto, Toshihiro Oguma, Ling He, Chris Lowrie and Jeanne Mendell
Drug Metabolism and Disposition December 2012, 40 (12) 2250-2255; DOI: https://doi.org/10.1124/dmd.112.046888
Mohinder S. Bathala
Daiichi Sankyo Pharma Development, Edison, New Jersey (M.S.B., H.M., T.O., L.H., J.M.); and Charles River Laboratories, Edinburgh, United Kingdom (C.L.)
Hiroshi Masumoto
Daiichi Sankyo Pharma Development, Edison, New Jersey (M.S.B., H.M., T.O., L.H., J.M.); and Charles River Laboratories, Edinburgh, United Kingdom (C.L.)
Toshihiro Oguma
Daiichi Sankyo Pharma Development, Edison, New Jersey (M.S.B., H.M., T.O., L.H., J.M.); and Charles River Laboratories, Edinburgh, United Kingdom (C.L.)
Ling He
Daiichi Sankyo Pharma Development, Edison, New Jersey (M.S.B., H.M., T.O., L.H., J.M.); and Charles River Laboratories, Edinburgh, United Kingdom (C.L.)
Chris Lowrie
Daiichi Sankyo Pharma Development, Edison, New Jersey (M.S.B., H.M., T.O., L.H., J.M.); and Charles River Laboratories, Edinburgh, United Kingdom (C.L.)
Jeanne Mendell
Daiichi Sankyo Pharma Development, Edison, New Jersey (M.S.B., H.M., T.O., L.H., J.M.); and Charles River Laboratories, Edinburgh, United Kingdom (C.L.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
PK AND MASS BALANCE OF EDOXABAN
Mohinder S. Bathala, Hiroshi Masumoto, Toshihiro Oguma, Ling He, Chris Lowrie and Jeanne Mendell
Drug Metabolism and Disposition December 1, 2012, 40 (12) 2250-2255; DOI: https://doi.org/10.1124/dmd.112.046888
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement